ICD-10-CM Billable Code

C44.112

Basal cell carcinoma of skin of right eyelid, including canthus

Clinical Classification Guidelines

Medical Intelligence & Overview

Basal cell carcinoma (BCC) of the skin is the most common type of skin cancer. When it occurs on the eyelid, particularly the right eyelid including the canthus (corner of the eye), it requires careful attention due to the functional and aesthetic importance of this area. This type of skin cancer typically develops slowly and rarely spreads to other parts of the body, but it can cause significant local tissue damage if not treated promptly. Recognizing its causes, symptoms, and available treatments can help in early diagnosis and management.

Causes & Symptoms

Clinical Causes: Prolonged and repeated exposure to ultraviolet (UV) radiation from sunlight or tanning beds. Fair skin that offers less protection against UV damage. Age-related changes, as BCC is more common in older adults. History of previous skin cancers or precancerous skin conditions. Genetic predispositions or inherited conditions that increase skin cancer risk. Immunosuppression, such as from organ transplants or certain medical treatments.

Key Symptoms: A small, shiny, or translucent bump on the eyelid. A persistent sore that doesn't heal or an ulcer with a pearly border. Resistance to healing or recurrent sores in the same area. A growth or lump that may be pink, reddish, or flesh-colored. Loss of eyelashes in the affected area. Changes in skin texture or pigmentation around the eyelid. Raised or rolled edges around the lesion.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of basal cell carcinoma usually involves a thorough dermatological examination of the eyelid and surrounding areas. A biopsy, where a small tissue sample is removed and examined microscopically, confirms the presence of cancerous cells. Imaging tests may be considered in certain cases to assess the extent of deep tissue involvement or to plan surgical removal. Given the sensitive location, a multidisciplinary approach often involves dermatologists, ophthalmologists, and plastic surgeons to evaluate the best course of action.

Treatment Protocols: Treatment options focus on removing the cancerous tissue while preserving the function and appearance of the eyelid. Common methods include: - Surgical excision, often with Mohs micrographic surgery, which ensures complete removal while sparing healthy tissue. - Cryotherapy, where extreme cold is used to destroy cancer cells. - Topical treatments like imiquimod cream or 5-fluorouracil for superficial lesions. - Radiation therapy, in cases where surgery isn’t feasible. - Reconstruction procedures to restore eyelid function and aesthetics post-removal. Follow-up care is essential to monitor for recurrence and to manage any complications arising from treatment.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C44.112 a billable ICD-10 code?
Yes, C44.112 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C44.112?
Clinical documentation must specify the nature of Basal cell carcinoma of skin of right eyelid, including canthus and any associated comorbidities for accurate reporting.

Cite this Clinical Reference